In vitro trials of some antimicrobial combinations against Staphylococcus aureus and Pseudomonas aeruginosa

Saudi Journal of Biological Sciences

Volumn 20, Issue 1, 2013, Pages 79-83

  Ahmed, Zafar ^a   Saeed Khan, Shaukat ^a   Khan, Mahnaaz ^a  

^a Department of Microbiology   (India)

Author keywords

Antimicrobial; FICI; MIC; MRSA; P. aeruginosa; S. aureus; Synergism

Indexed keywords

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84871685933     PISSN: 1319562X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjbs.2012.10.005     Document Type: Article

References (25)

1. Adegoke A.A., Komolafe A.O. Multi-drug resistant Staphylococcus aureus in clinical cases in Ile-Ife, Southwest Nigeria. Int. J. Med. Sci. 2009, 1:68-72.
2. Anjum F., Mir A. Susceptibility pattern of Pseudomonas aeruginosa against various antibiotics Afr. J. Microbiol. Res. 2010, 4:1005-1012.
3. Bauer R.W., Kirby M.D.K., Sherris J.C., Turck M. Antibiotic susceptibility testing by standard single disc diffusion method. Am. J. Clin. Pathol. 1966, 45:493-496.
4. Burke J.P. Infection Control-A Problem for Patient Safety. New Engl. J. Med. 2003, 348:651-656.
5. Cai Y., Wang R., Pei F., Liang B. Antibacterial activity of Allicin alone and in combination with β-lactams against Staphylococcus spp. and Pseudomonas aeruginosa. J. Antibiot. 2007, 60:335-338.
6. Desbiolles N., Piroth L., Lequeu C., Neuwirth C., Portier H., Chavanet P. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 2001, 45:3328-3333.
7. Gutmann L., Williamson R., Kitiz M.D., Acar J.F. Synergism and antagonism in double beta-lactam antibiotic combinations. Am. J. Med. 1986, 30:21-29.
8. Haghi M., Maadi H., Delshad R., Nezhady M.A.M., et al. Antibiotic resistance pattern of Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa isolated from burnt patients Urmia. Iran. Inter. J. Aca. Res. 2010, 2:377-380.
9. Hauser A.R., Sriram P. Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistance. Postgrad. Med. 2005, 117:41-48.
10. Jones R.N., Johnson D.M. Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 1998, 31:373-376.
11. Kondo S., Ikeda Y., Hattori S., Hamada M., et al. Susceptibility of methicillin-resistant Staphylococcus aureus to various antibiotics. Classification by aminoglycoside-modifying enzymes and antibiotics active against MRSA. Jpn. J. Antibiot. 1991, 44:1211-1215.
12. Konno M. Nosocomial infections caused by methicillin-resistant S. aureus in Japan. J. Infect. Chemother. 1995, 1:30-39.
13. Livermore D.M. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods. Eur. J. Clin. Microbiol. 1987, 6:439-445.
14. Livermore D.M. Role of Beta-lactamase and impermeability in the resistance of P. aeruginosa. Antibiot. Chemother. 1989, 42:257-263.
15. Maltezou H.C., Giamarellou H. Community-acquired methicillin-resistant Staphylococcus aureus infections. Int. J. Antimicrob. Agents 2006, 27:87-96.
16. Matsumoto Y. Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumonia infection. Chemotherapy 1998, 44:6-9.
17. National committee for Clinical Laboratory Standards, 2002. Performance standard for antimicrobial susceptibility testing; Twelfth Information Supplement. NCCLS Document M100-S12.
18. Pasticci M.B., Mencacci A., Moretti A., Palladino N., et al. In vitro Antimicrobial Activity of Ampicillin-Ceftriaxone and Ampicillin-Ertapenem Combinations Against Clinical Isolates of Enterococcus faecalis with High Levels of Aminoglycoside Resistance. Open Microbiol. J. 2008, 2:79-84.
19. Prinsloo A., Straten V.A.M.S., Weldhagen G.F. Antibiotic synergy profiles of multidrug-resistant Pseudomonas aeruginosa in a nosocomial environment. South Afr. J. Epidemiol. Infect. 2008, 2:7-9.
20. Rigby A. Thermonuclease testing: the rapid identification of Staphylococcus aureus in blood culture Med. Lab. Science. 1986, 43:196-198.
21. Safdar N., Crnich C.J., Maki D.G. Nosocomial infections in the intensive care unit associated with invasive medical devices. Curr. Infect. Dis. Rep. 2001, 1:487-495.
22. Shahid M., Malik A. Plasmid mediated amikacin resistance in clinical isolates of Pseudomonas aeruginosa. Ind. J. Med. Microbiol. 2004, 22:182-184.
23. Shimizu K., Orizu M., Kanno H., Kitamura S., et al. Clinical studies on vancomycin in the treatment of MRSA infection. Jpn. J. Antibiot. 1996, 49:782-799.
24. Tascini C., Doria R., Leonildi A., Martinelli C., Menichetti F. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the " ex vivo" synergism method. J. Chemother. 2004, 16:400-403.
25. Prevention of hospital-acquired infections A practical guide 2nd edition, WHO/CDS/CSR/EPH/2002.12.